Moderna
MRNA
#430
Rank
NZ$99.67 B
Marketcap
NZ$249.66
Share price
-1.99%
Change (1 day)
526.17%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -NZ$5.32 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$2.20 Billion. In 2025 the company made an earning of -NZ$4.79 Billion, an increase over its 2024 earnings that were of -NZ$6.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$5.32 Billion11.03%
2025 -NZ$4.79 Billion-23.03%
2024 -NZ$6.23 Billion-8.22%
2023 -NZ$6.78 Billion-140.65%
2022 NZ$16.67 B-27.81%
2021 NZ$23.10 B-1911.15%
2020 -NZ$1.28 Billion44.7%
2019 -NZ$0.89 Billion28.63%
2018 -NZ$0.69 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.11 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.40 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$22.83 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$82.37 Million-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$72.52 Million-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.51 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.28 Billion-94.86%๐Ÿ‡บ๐Ÿ‡ธ USA